SUDARSHAN PHARMA Q2 Result
NET PROFIT UP 23 % AT CR (YOY),DOWN 8 % (QOQ)
REVENUE DOWN 2 % AT 227.7 CR (YOY) ,DOWN 2 % (QOQ)
EBITDA UP 98 % AT 16.56 CR (YOY),UP 15 %(QOQ)
MARGINS AT 7.25 % V 3.6 % (YOY),6.21 % (QOQ)
NET PROFIT UP 23 % AT CR (YOY),DOWN 8 % (QOQ)
REVENUE DOWN 2 % AT 227.7 CR (YOY) ,DOWN 2 % (QOQ)
EBITDA UP 98 % AT 16.56 CR (YOY),UP 15 %(QOQ)
MARGINS AT 7.25 % V 3.6 % (YOY),6.21 % (QOQ)